Open AccessClinical guidelines «Polycystic Ovary Syndrome»
Author(s) -
L.V. Adamyan,
Е. Н. Андреева,
Yu. S. Absatarova,
O. R. Grigoryan,
Ivan I. Dedov,
G. A. Melnichenko,
Larisa Suturina,
O. S. Filippov,
E. V. Sheremetyeva,
Chernukha G.E. Chernukha,
Maria I. Yarmolinskaya
Publication year - 2022
Publication title -
problemy èndokrinologii
Language(s) - English
Resource type - Journals
eISSN - 2308-1430
pISSN - 0375-9660
DOI - 10.14341/probl12874
Subject(s) - polycystic ovary , medicine , gynecology , endocrine system , obstetrics and gynaecology , disease , genetic counseling , family medicine , endocrinology , biology , pregnancy , diabetes mellitus , insulin resistance , hormone , genetics
Polycystic ovary syndrome (PCOS) is a polygenic endocrine disorder caused by both genetic and epigenetic factors. Depending on the period of a woman’s life, the clinical picture, diagnosis, and treatment tactics of the disease are different. PCOS has a complex of reproductive, metabolic and psychological characteristics. The target audience of these clinical recommendations are obstetrician-gynecologists, endocrinologists, general practitioners, general practitioners. In these clinical guidelines, all information is ranked according to the level of persuasiveness of recommendations and the reliability of evidence, depending on the number and quality of studies on this issue.